🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Let's talk neuroendocrine oncology and Radiopharmaceuticals over a cup of coffee in beautiful Chicago. See ya soon And don't forget to checkout our #ASCO25 abstracts #DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung

I am very honored to be nominated for Director of Membership of ESMO - Eur. Oncology Election. 😊 the President’s call: #ESMOMembers vote for leaders who’ll shape ESMO’s future. Vote for Directors of Education, Public Policy & Membership , and Chair and members of the Nomination Committee

What a day! We consented two patients to our SVV-Ipi-Nivo study (NCT06889493) for high-grade neuroendocrine cancer—closing Cohort 1 in under a month! To add to the momentum, we received incredible news of a generous philanthropic gift from the Nichole Borchard Foundation to

Thank you OncLive.com Benjamin Levy for organizing fellows forum! An incredible learning opportunity. Eric K. Singhi, MD Narjust Florez, MD, FASCO Sandip Patel MD FASCO Christine Garcia, MD, MPH Kristen A. Marrone, MD Sylvester Comprehensive Cancer Center

Our rising superstar Chinmay Jani

Good Morning Chicago. #ASCO25

Have you signed up for #MiamiNights yet? Sylvester Comprehensive Cancer Center @asco #asco25 We are hiring - Looking for chiefs for breast and head and neck and oncologists in pretty much all areas DM me @glopesmd

Doctors from across continents and dedicated patient advocates reconnecting at #ASCO25 — a true reflection of the global spirit of ASCO.

Just arrived in Chicago! 🌆 Excited to present on trends in breast cancer mortality & contributing risk factors ASCO 🗓️ Join me TOMORROW Saturday 5/31 at my poster session: 🕜 1:30 PM – 4:30 PM 📍 Hall A, Poster Board 327 Can’t wait to connect! #ASCO25 #BreastCancer

Great presentation by Peter Hosein, MD from Sylvester Comprehensive Cancer Center on pancreas subtypes. Nice to see progress in pancreatic cancer with use of vaccines.

Thank you to everyone who joined us at our Miami Nights reception during the 2025 American Society of Clinical Oncology Annual Meeting in #Chicago! It was an unforgettable evening where we celebrated oncology professionals who are shaping the future of cancer care. #ASCO25

😇 Honored to lead & present topline Ph 2 data for DSP107 +/- Atezolizumab in 3L MSS CRC #ASCO25: 🔹 Median OS: 17 months >> 60% improvement over SOC. 🔹 ~80% with liver metastases—the most challenging subset. 🔜 a randomized Phase 2b trial to advance this promising approach ✨

Kicked off my first day at the new Sylvester Griffin Cancer Research Building by enrolling a patient in Dr. Soares’s Adjuvant CAPTEM study for pNETs during clinic—excited to hit the ground running! Sylvester Comprehensive Cancer Center Heloisa Soares MD

Alright! It’s Friday after ASCO and I finally have time to tweet again :) Full #ASCO25 Symplur report for most influential tweeters. Thank you for following all of us and for being part of the family! And especially for amplifying messages that will help improve care for

Just yesterday, I was consulted on two newly diagnosed cases of gastric NEC—one localized, one advanced. I know, incredibly rare! A timely reminder that NETs and NECs are worlds apart and demand fundamentally different diagnostic workups and treatment strategies. The silver

Had a great time discussing the latest advances in high-grade neuroendocrine carcinoma with my amazing NANETS colleagues on the #NETCAST podcast. 🎙️ Promising Advances in NEC Research and Treatment Tune in here: art19.com/shows/netcast/… #NeuroendocrineCancer #NEC #NANETS

Join us virtually this Saturday! Over 800 registered already. I’ll be speaking on PRRT toxicity and the latest advances in the field—don’t miss it! Neuroendocrine Cancer Foundation Sylvester Comprehensive Cancer Center

It is with deep sadness that we share the passing of Dr. Richard R.P. Warner, who left us on June 15, 2025 in Denver, Colorado at the age of 97. A visionary physician and researcher, Dr. Warner founded the Carcinoid Cancer Foundation in 1968. His tireless work has touched

Grateful to the Phase 1 Team at Ohio State University for the opportunity to present on hPG80, a promising new blood-based biomarker. We’re excited to validate its role in disease monitoring through ETCTN 10588—a multicenter randomized study now nearing completion. Later, I had

🎉 Congrats to Chinmay Jani for an insightful talk on his research work on global #LungCancer trends and biomarker-driven #immunotherapy strategies to overcome ICI resistance! 🔬gilberto lopes Dr. Estela Rodriguez Marijo Bilusic, MD, PhD Aman Chauhan Dionysios (Dennis) Watson Sylvester Comprehensive Cancer Center